Newsroom
Velcade Approved by the FDA for Retreatment of MM patients
The approval follows results from the RETRIEVE trial, conducted in patients who had previously responded to Velcade but had relapsed.
Short-Term Health Plans Might Offer Some Relief But They Have Significant Gaps
Consumers who missed open enrollment on the state health insurance marketplaces this spring or who are waiting for employer coverage to start don’t have to "go bare."
WHO: Ebola Outbreak Is International Public Health Emergency
The World Health Organization declared an international public health emergency Friday over the Ebola outbreak in western Africa that has killed almost 1,000 people. The outbreak of the deadly virus is “extraordinary event” and a public health risk to other countries, it said.
Genetic Make-up, Not Tissue of Origin, Should Dictate Cancer Treatment: New Study
The research, published in the journal Cell, proposes revising treatment based on the molecular constitution of the tumor when it presents itself, rather than the tissue or organ of origin.
The Value Discussion in Cancer Care Escalates: NICE and Roche
According to Sir Andrew Dillon, chief executive of NICE, the high price that Roche is demanding for Kadcyla is beyond the means of NHS to cover.
Hospice Discharges in the South Raise Questions
High rate of hospice survivors, especially in Alabama and Mississippi, have raised doubts about improper practices.
Novel ER Gene Fusion Identified in Luminal B Breast Cancer
Published in Nature Communications, the study identified a new gene fusion and rearrangement of the estrogen receptor, responsible for the aggressive nature of luminal B breast cancer.
Six Wisconsin Systems Create Pact, Aim for ACO
Six of the most prominent healthcare systems in Wisconsin have created a new partnership, jumping on the nationwide bandwagon of forming strategic alliances to share information, while remaining independent.
Obamacare Creates 'Upheaval' At Free Clinics
While a few free health clinics have shut their doors in Arkansas and Washington, most expansion-state non-profit free clinics are reassessing their business strategies.
The PSA Debate Continues
The Lancet study, conducted in Europe, found a survival benefit with early diagnosis, but does not agree that the benefit outweighs some of the associated risks of the test.
Mutation in a BRCA2-Related Gene: Increased Risk of Breast Cancer
The study, published in NEJM, proposes enhanced surveillance in women with PALB2 mutations, similar to women harboring BRCA2 mutations.
How Employer-Based Health Insurance Actually Is Cheaper Than Government-Sponsored Insurance
Comparing the cost of employer-sponsored insurance to the cost of either Medicare or Medicaid is a completely stacked comparison even if we fully adjust for every iota of age and health status differences between these three populations and use an apples-to-apples comparison of plans having the identical benefits and actuarial value.
Use of Experimental Ebola Drug Raises Red Flags Among Medical Experts
What looks like a simple case of humanitarian goodwill could lead to some unintended and very negative consequences, experts said Tuesday.
Feds Stop Public Disclosure of Many Serious Hospital Errors
The federal government this month quietly stopped publicly reporting when hospitals leave foreign objects in patients' bodies or make a host of other life-threatening mistakes.
Cerner Spending $1.3 Billion for Siemens Health Tech Unit
Health technology and electronic health-record powerhouse Cerner Corp. is spending $1.3 billion to purchase Siemens Health Services, Siemens' health information technology business, Cerner announced Tuesday.
Senators Enquire on Policy for Biosimilars
Within a week of Sandoz applying for approval of it's biosimlar to Amgen's Neupogen, U.S. senators want the FDA to lay down guidelines on naming these drugs.
Experimental Drug Likely Saved Ebola Patients
On July 30, the Defense Threat Reduction Agency, an arm of the military responsible for any chemical, biological, radiological, nuclear and high-yield explosive threats, allotted additional funding to MAPP Biopharmaceutical due to "promising results."
Insurance Giants Creating Massive Database of Patient Records
Two of California's largest health insurers are partnering to create a massive database of patient medical records.
CMS Issues Final Rules for Inpatient, Hospice Payments
The CMS has finalized a rule (PDF) that decreases inpatient prospective payment system payments by $756 million overall. Meanwhile, long-term-care hospitals will see payments increase by 1.1%, or approximately $62 million in fiscal 2015, which starts Oct. 1.
FDA Accepts sNDA for Incyte's Jakafi
The results of ruxolitinib's RESPONSE trial were recently presented at ASCO's annual meeting.
AbbVie's Investigational Compound Receives Orphan Drug Designation by Both the FDA and EMA
ABT-414 is being developed to treat glioblastoma multiforme.
Hospital, Insurer Earnings Show Mixed Messages About Health Spending
Analysts who fear health spending is accelerating got plenty of evidence in Wall Street's second-quarter results to support their thesis. But so did folks who hope spending is still under control.
Justice Dept. Seeks Appeal in Health Overhaul Case
The Justice Department asked a full federal appeals court Friday to take up a case that has endangered subsidies helping millions of low- and middle-income people to afford their healthcare premiums under Obamacare.
Amgen's ASPIRE Trial Meets Primary Endpoint in Phase 3 for MM
The study evaluated carfilzomib in combination with Celgene's lenalidomide and dexamethasone.
Express Scripts Makes Value-Based Decisions for its Formulary
The pharmacy benefit manager has decided to choose formulations that provide equivalent benefit at lower cost.